Roivant Sciences Increase (Decrease) in Accounts Payable, Trade increased by 505.1% to $16.16M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9890.9%, from -$165.00K to $16.16M. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates the company is effectively extending its payment terms to preserve cash, while a decrease suggests faster settlement of liabilities.
The net change in trade accounts payable, representing the company's management of its obligations to suppliers for good...
Reflects the company's bargaining power with suppliers; larger firms often maintain higher payable balances relative to sales.
other_increase_decrease_in_accounts_payable_trade| Q1 '21 | Q2 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q4 '23 | Q1 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$6.34M | $62.85M | $11.71M | -$19.45M | $26.23M | $7.20M | $11.94M | $20.89M | -$25.27M | -$165.00K | -$11.75M | $3.00M | -$3.99M | $16.16M |
| QoQ Change | — | >999% | -81.4% | -266.1% | +234.8% | -72.6% | +65.9% | +74.9% | -221.0% | +99.3% | <-999% | +125.5% | -233.1% | +505.1% |
| YoY Change | — | — | — | -206.7% | -58.3% | — | +161.4% | — | -311.6% | -100.8% | +53.5% | — | — | >999% |